2018

October 18, 2018

LogicBio Therapeutics Announces Pricing of Initial Public Offering

May 23, 2018

LogicBio Therapeutics Appoints Dean Falb, Ph.D., as Chief Scientific Officer

May 14, 2018

LogicBio Therapeutics to Present Data on GeneRide™ Platform Technology

May 9, 2018

LogicBio Therapeutics Launches Development Program in Methylmalonic Acidemia (MMA)

May 2, 2018

LogicBio Therapeutics Strengthens Leadership Team with Key Appointments

January 2, 2018

LogicBio Therapeutics Announces Expansion of Leadership Team through Multiple Key Hires

2017

October 16, 2017

LogicBio Therapeutics to Present Preclinical Data at European Society of Gene & Cell Therapy 25th Anniversary Congress in Berlin

June 27, 2017

LogicBio Therapeutics Announces $50 Million in Financing to Develop Novel Gene Medicines for Pediatric Patients